Trial Profile
An Open Label, Expanded Access Study of Melphalan Chemosaturation With the Delcath System in Patients With Ocular and Cutaneous Melanoma Metastatic to the Liver
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 18 Mar 2022
Price :
$35
*
At a glance
- Drugs Melphalan (Primary)
- Indications Liver metastases; Malignant melanoma; Uveal melanoma
- Focus Expanded access; Therapeutic Use
- 19 Dec 2012 New trial record